Post job

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) demographics summary. Zippia estimates demographics and statistics for International Society for Pharmacoeconomics and Outcomes Research (ISPOR) by using a database of 30 million profiles. Our estimates are verified against BLS, Census, and current job openings data for accuracy. After extensive research and analysis, Zippia's data science team found that:

  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has 31 employees.
  • 57% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are women, while 43% are men.
  • The most common ethnicity at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is White (63%).
  • 13% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are Black or African American.
  • 11% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are Hispanic or Latino.
  • The average employee at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) makes $45,946 per year.
  • Employees at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) stay with the company for 6.7 years on average.
Work at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?
Share your experience
Number of employees
31
Company number of employees
Gender
Male - 42%
Female - 57%
Company gender
Race
White - 63%
Black or African American - 13%
Company gender

Jobs from similar companies

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employee diversity statistics

  • 57% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are female.
  • 63% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are white.
9.3
Diversity score
We calculate the diversity score of companies by measuring multiple factors, including the ethnic background, gender identity, and language skills of their workforce.
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) CEOHarry J. Smolen
Industry-
Company typePrivate
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees who are women57%
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) executives who are women80%
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees who are minorities37%
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) executives who are minorities39%
Most common minority at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)Black or African American
Most common foreign languageFrench

Rate International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s commitment to diversity and inclusion.

Zippia waving zebra

Compare International Society for Pharmacoeconomics and Outcomes Research (ISPOR) diversity with other companies

Gender ratio

Male

42.6 %

Female

57.4 %

Ethnicity

White

63.6 %

Black or African American

13.2 %

Hispanic or Latino

10.7 %

Foreign languages spoken

French

25.0 %

Spanish

25.0 %

Portuguese

12.5 %
Work at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?
Share your experience
Number of employees
31
Company number of employees
Gender
Male - 42%
Female - 57%
Company gender
Race
White - 63%
Black or African American - 13%
Company gender

Jobs from similar companies

Do you work at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?

Does International Society for Pharmacoeconomics and Outcomes Research (ISPOR) actively promote diversity and inclusion?

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees education

  • The most common highest degree level of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees is bachelors, with 60% of employees having at least a bachelors.
  • The most common major among International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees is business. 12% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees majored in business.

Schools of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees

Johnson & Wales University

17.9 %

University of North Carolina at Greensboro

10.3 %

University of South Florida

7.7 %

Majors of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees

Business

11.8 %

English

9.2 %

Marketing

7.9 %

Degrees of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees

Bachelors

60.4 %

Masters

20.8 %

Doctorate

6.6 %

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) demographics by department

  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a female-dominated company. 43% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are male and 57% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are female.
  • The most common race/ethnicity at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is White. 63% of employees at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) are White.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) gender ratio

GenderPercentages
Female52.2%
Male47.8%
  • Female, 52.2%
  • Male, 47.8%

Racial distribution at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

RacePercentages
White70.0%
Black or African American15.0%
Asian10.0%
Hispanic or Latino5.0%
Unknown0.0%
  • White, 70%
  • Black or African American, 15%
  • Asian, 10%
  • Hispanic or Latino, 5%
  • Unknown, 0%

Jobs from companies you might like

What is the average age of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees?

  • The most common age range of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees is 20-30 years. 100% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are between the ages of 20-30 years.
  • The least common age range of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees is less than 18 years. 0% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are between the ages of less than 18 years.

Less than 18 years

18-20 years

20-30 years

30-40 years

40+ years

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employee average age

Employees agePercentages
Less than 18 years0%
18-20 years0%
20-30 years100%
30-40 years0%
40+ years0%

What is the average length of employment at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?

  • A plurality of employees at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) stay for 1-2 years. 28% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees stay at the company for 1-2 years.
  • It's rare for an employee to stay with International Society for Pharmacoeconomics and Outcomes Research (ISPOR) for 8-10 years. Only 12% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees stay at the company for 8-10 years.

Less than one year

1-2 years

3-4 years

5-7 years

8-10 years

11+ years

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees' length of employment

Number or YearsPercentages
Less than one year14%
1-2 years28%
3-4 years12%
5-7 years15%
8-10 years12%
11+ years20%

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) salary range

  • A plurality of employees at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) earns $40k-60k. 33% of employees earn a salary of $40k-60k a year.
  • The least common salary at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is <$25k. Only 5% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees earn a salary of <$25k a year.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) competitor salary comparison

<$25k

4.6 %

$25k-40k

29.4 %

$40k-60k

33.1 %

$60k-100k

27.1 %

$100k-200k

5.8 %

>$200k

0.1 %

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) job listings by salary range

Salary rangeInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR)
<$25k2,528,141 jobs-
$25k-40k16,025,275 jobs-
$40k-60k18,034,192 jobs-
$60k-100k14,787,521 jobs-
$100k-200k3,138,317 jobs-
>$200k35,502 jobs-

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) demographics FAQs

How many employees does International Society for Pharmacoeconomics and Outcomes Research (ISPOR) have?

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has 31 employees.

Zippia gives an in-depth look into the details of International Society for Pharmacoeconomics and Outcomes Research (ISPOR), including salaries, political affiliations, employee data, and more, in order to inform job seekers about International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The employee data is based on information from people who have self-reported their past or current employments at International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The data presented on this page does not represent the view of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and its employees or that of Zippia.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) may also be known as or be related to INTERNATIONAL SOCIETY FOR, International Society For Pharmacoeconomics And Outcomes Research ..., International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Joshua Friedman.